{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:12:25Z","timestamp":1788487945655,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Complementary and alternative medicine (CAM) therapies are increasingly popular; however, comprehensive data on their usage patterns and types remain limited, especially in South Korea. We investigated the patterns and economic impact of CAM use in thyroid cancer after lobectomy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We utilized data from the MASTER study, a prospective, multicenter, randomized, controlled trial on patients with differentiated thyroid cancer post-lobectomy. Data on CAM usage in 1,166 patients at baseline and at 3, 6, and 12 months postoperatively were included. Logistic regression quantified the effect of levothyroxine treatment on CAM usage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      CAM use was reported by 58% of participants. Dietary nutritional products were the most used CAM modality, with usage rates of 42.5% at baseline, decreasing to 37.7% at 12 months. Exercise and physical therapies also showed significant differences, with 19.2% using these modalities at baseline, increasing to 27.1% at 12 months. The median cost for CAM varied, with dietary products consistently costing 144 USD (200,000 KRW) and exercise costs rising from 144 USD (200,000 KRW) to 288 USD (400,000 KRW) over time. Patients on levothyroxine were less likely to use CAM, with an odds ratio (OR) of 0.57 (95% confidence interval [CI]\u2009=\u20090.45\u20130.72,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). However, levothyroxine users who did use CAM were more likely to use multiple CAM modalities, with an OR of 3.66 (95% CI\u2009=\u20091.88\u20137.14,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.001) at baseline, though this association did not remain significant later.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CAM is integrated into thyroid cancer treatment, indicating a need for healthcare professionals to discuss its safety and effective care integration.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12906-026-05428-w","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T09:26:39Z","timestamp":1782206799000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patterns of complementary and alternative medicine use and factors influencing its utilization in thyroid cancer: findings from the MASTER study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6896-9024","authenticated-orcid":false,"given":"Han-Sang","family":"Baek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1538-8859","authenticated-orcid":false,"given":"Mijin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9007-7025","authenticated-orcid":false,"given":"Kyungsik","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8305-0246","authenticated-orcid":false,"given":"Woojin","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6403-6035","authenticated-orcid":false,"given":"Kwangsoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6271-2105","authenticated-orcid":false,"given":"Ja Seong","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0995-6482","authenticated-orcid":false,"given":"Dong-Jun","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3918-7717","authenticated-orcid":false,"given":"Eun-Jae","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5928-0006","authenticated-orcid":false,"given":"Bon Seok","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4865-5677","authenticated-orcid":false,"given":"Sung Yong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0098-0873","authenticated-orcid":false,"given":"Eun Kyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5533-4989","authenticated-orcid":false,"given":"Eu Jeong","family":"Ku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5878-6005","authenticated-orcid":false,"given":"Kyeong Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1617-3171","authenticated-orcid":false,"given":"Hee Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9990-607X","authenticated-orcid":false,"given":"June Young","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9632-9457","authenticated-orcid":false,"given":"Bo Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5002-9707","authenticated-orcid":false,"given":"Sue K.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"5428_CR1","unstructured":"National Center for Complementary and Integrative Health (NCCIH). Complementary, alternative, or integrative health: what's in a name? [Internet]. Bethesda (MD): NCCIH; 2021. Available from: https:\/\/www.nccih.nih.gov\/health\/complementary-alternative-or-integrative-health-whats-in-a-name. Cited 2026 Jun 5."},{"issue":"2","key":"5428_CR2","first-page":"144","volume":"72","author":"JJ Mao","year":"2022","unstructured":"Mao JJ, Pillai GG, Andrade CJ, Ligibel JA, Basu P, Cohen L, Khan IA, Mustian KM, Puthiyedath R, Dhiman KS, et al. Integrative oncology: Addressing the global challenges of cancer prevention and treatment. CA Cancer J Clin. 2022;72(2):144\u201364.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"5428_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/jnci\/djab048","volume":"114","author":"LG Balneaves","year":"2022","unstructured":"Balneaves LG, Watling CZ, Hayward EN, Ross B, Taylor-Brown J, Porcino A, Truant TLO. Addressing complementary and alternative medicine use among individuals with cancer: an integrative review and clinical practice guideline. J Natl Cancer Inst. 2022;114(1):25\u201337.","journal-title":"Jnci-J Natl Cancer I"},{"key":"5428_CR4","first-page":"2211","volume":"39","author":"M Yousefi","year":"2024","unstructured":"Yousefi M, Reihani H, Heydari M, Azgomi RND, Hashempur MH. Complementary and alternative medicine use among cancer patients in Iran: a systematic review. Prev Med Rep. 2024;39:2211\u20133355.","journal-title":"Prev Med Rep"},{"issue":"3","key":"5428_CR5","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.3390\/ijerph19031600","volume":"19","author":"K Kasprzycka","year":"2022","unstructured":"Kasprzycka K, Kurzawa M, Kucharz M, Godawska M, Oleksa MA-O, Stawowy M, Slupinska-Borowka K, Sznek WA-O, Gisterek IA-O, Boratyn-Nowicka A, et al. Complementary and Alternative Medicine Use in Hospitalized Cancer Patients-Study from Silesia, Poland. Int J Environ Res Public Health. 2022;19(3):1600.","journal-title":"Int J Environ Res Public Health"},{"issue":"5","key":"5428_CR6","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s00432-021-03675-7","volume":"148","author":"C Wolf","year":"2022","unstructured":"Wolf C, Rachow T, Ernst T, Hochhaus A, Zomorodbakhsch B, Foller S, Rengsberger M, Hartmann M, Huebner J. Complementary and alternative medicine (CAM) supplements in cancer outpatients: analyses of usage and of interaction risks with cancer treatment. J Cancer Res Clin Oncol. 2022;148(5):1123\u201335.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"5428_CR7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12906-019-2452-5","volume":"19","author":"K Wode","year":"2019","unstructured":"Wode K, Henriksson R, Sharp L, Stoltenberg A, Hok Nordberg J. Cancer patients\u2019 use of complementary and alternative medicine in Sweden: a cross-sectional study. BMC Complement Altern Med. 2019;19(1):62.","journal-title":"BMC Complement Altern Med"},{"issue":"15","key":"5428_CR8","doi-asserted-by":"publisher","first-page":"24401","DOI":"10.18632\/oncotarget.14224","volume":"8","author":"M Berretta","year":"2017","unstructured":"Berretta M, Della Pepa C, Tralongo P, Fulvi A, Martellotta F, Lleshi A, Nasti G, Fisichella R, Romano C, De Divitiis C, et al. Use of Complementary and Alternative Medicine (CAM) in cancer patients: An Italian multicenter survey. Oncotarget. 2017;8(15):24401\u201314.","journal-title":"Oncotarget"},{"issue":"3","key":"5428_CR9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1177\/1534735411423920","volume":"11","author":"M Horneber","year":"2012","unstructured":"Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M. How Many Cancer Patients Use Complementary and Alternative Medicine: A Systematic Review and Metaanalysis. Integr Cancer Ther. 2012;11(3):187\u2013203.","journal-title":"Integr Cancer Ther"},{"issue":"10","key":"5428_CR10","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1089\/thy.2012.0495","volume":"23","author":"JE Rosen","year":"2013","unstructured":"Rosen JE, Gardiner P, Saper RB, Filippelli AC, White LF, Pearce EN, Gupta-Lawrence RL, Lee SL. Complementary and Alternative Medicine Use Among Patients with Thyroid Cancer. Thyroid. 2013;23(10):1238\u201346.","journal-title":"Thyroid"},{"issue":"34","key":"5428_CR11","doi-asserted-by":"publisher","first-page":"e264","DOI":"10.3346\/jkms.2023.38.e264","volume":"38","author":"H-S Baek","year":"2023","unstructured":"Baek H-S, Ha JH, Kim KS, Bae JS, Kim JS, Kim SJ, Lim D-J, Kim CM. Cost-Effectiveness of Active Surveillance Compared to Early Surgery of Small Papillary Thyroid Cancer: A Retrospective Study on a Korean Population. J Korean Med Sci. 2023;38(34):e264.","journal-title":"J Korean Med Sci"},{"issue":"1","key":"5428_CR12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3803\/EnM.2023.1794","volume":"39","author":"JH Yoon","year":"2024","unstructured":"Yoon JH, Choi W, Park JY, Hong AR, Kim HK, Kang H-C. Active surveillance for low-risk papillary thyroid carcinoma as an acceptable management option with additional benefits: a comprehensive systematic review. Endocrinol Metab (Seoul). 2024;39(1):152\u201363.","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"5","key":"5428_CR13","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3803\/EnM.2023.1723","volume":"38","author":"YM Choi","year":"2023","unstructured":"Choi YM, Kim M-J, Lee J, Kwak MK, Jeon MJ, Kim TY, Hong E-G, Kim WB, Kim WG. Long-term changes in the mortality rates of thyroid cancer in Korea: analysis of Korean national data from 1985 to 2020. Endocrinol Metab (Seoul). 2023;38(5):588\u201395.","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"6","key":"5428_CR14","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1089\/thy.2021.0679","volume":"32","author":"K Kim","year":"2022","unstructured":"Kim K, Choi JY, Kim SJ, Lee EK, Lee YK, Ryu JS, Lee KE, Moon JH, Park YJ, Cho SW, et al. Active Surveillance Versus Immediate Surgery for Low-Risk Papillary Thyroid Microcarcinoma Patients in South Korea: A Cost-Minimization Analysis from the MAeSTro Study. Thyroid. 2022;32(6):648\u201356.","journal-title":"Thyroid"},{"issue":"3","key":"5428_CR15","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1001\/jamaoto.2018.3870","volume":"145","author":"B Nickel","year":"2019","unstructured":"Nickel B, Tan T, Cvejic E, Baade P, McLeod DSA, Pandeya N, Youl P, McCaffery K, Jordan S. Health-Related Quality of Life After Diagnosis and Treatment of Differentiated Thyroid Cancer and Association With Type of Surgical Treatment. JAMA Otolaryngol Head Neck Surg. 2019;145(3):231\u20138.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"5","key":"5428_CR16","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1007\/s11764-016-0530-y","volume":"10","author":"GM John","year":"2016","unstructured":"John GM, Hershman DL, Falci L, Shi ZX, Tsai WY, Greenlee H. Complementary and alternative medicine use among US cancer survivors. J Cancer Surviv. 2016;10(5):850\u201364.","journal-title":"J Cancer Surviv"},{"issue":"4","key":"5428_CR17","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3904\/kjim.2004.19.4.250","volume":"19","author":"MJ Kim","year":"2004","unstructured":"Kim MJ, Lee SD, Kim DR, Kong YH, Sohn WS, Ki SS, Kim J, Kim YC, Han CJ, Lee JO, et al. Use of complementary and alternative medicine among Korean cancer patients. Korean J Intern Med. 2004;19(4):250\u20136.","journal-title":"Korean J Intern Med"},{"issue":"1","key":"5428_CR18","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12906-017-1660-0","volume":"17","author":"Y Veziari","year":"2017","unstructured":"Veziari Y, Leach MJ, Kumar S. Barriers to the conduct and application of research in complementary and alternative medicine: a systematic review. BMC Complement Altern Med. 2017;17(1):166.","journal-title":"BMC Complement Altern Med"},{"issue":"1","key":"5428_CR19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.joim.2017.12.001","volume":"16","author":"A de Andrade","year":"2018","unstructured":"de Andrade A, FabianaSchlechta, Portella, Fabio C. Research methods in complementary and alternative medicine: an integrative review. J Integr Med. 2018;16(1):6\u201313.","journal-title":"J Integr Med"},{"issue":"4","key":"5428_CR20","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3803\/EnM.2021.1164","volume":"36","author":"K Kim","year":"2021","unstructured":"Kim K, Kim M, Lim W, Kim BH, Park SK. The Concept of Economic Evaluation and Its Application in Thyroid Cancer Research. Endocrinol Metab (Seoul). 2021;36(4):725\u201336.","journal-title":"Endocrinol Metab (Seoul)"},{"key":"5428_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ejon.2018.01.012","volume":"33","author":"KS Kim","year":"2018","unstructured":"Kim KS, Kim SH, Ok ON, Kim I-R, Lee S, Kim SH, Kim WS, Ryu M-H, Lee MH. Use of complementary and alternative medicine by lymphoma survivors in South Korea. Eur J Oncol Nurs. 2018;33:91\u20136.","journal-title":"Eur J Oncol Nurs"},{"issue":"3","key":"5428_CR22","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3803\/EnM.2020.943","volume":"36","author":"EK Lee","year":"2021","unstructured":"Lee EK, Kang YE, Park YJ, Koo BS, Chung KW, Ku EJ, Won HR, Yoo WS, Jeon E, Paek SH, et al. A Multicenter, Randomized, Controlled Trial for Assessing the Usefulness of Suppressing Thyroid Stimulating Hormone Target Levels after Thyroid Lobectomy in Low to Intermediate Risk Thyroid Cancer Patients (MASTER): A Study Protocol. Endocrinol Metab (Seoul). 2021;36(3):574\u201381.","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"1","key":"5428_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2015","unstructured":"Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2015;26(1):1\u2013133.","journal-title":"Thyroid"},{"issue":"1","key":"5428_CR24","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3803\/EnM.2017.32.1.106","volume":"32","author":"WG Kim","year":"2017","unstructured":"Kim WG, Kim WB, Woo G, Kim H, Cho Y, Kim TY, Kim SW, Shin MH, Park JW, Park HL, et al. Thyroid Stimulating Hormone Reference Range and Prevalence of Thyroid Dysfunction in the Korean Population: Korea National Health and Nutrition Examination Survey 2013 to 2015. Endocrinol Metab (Seoul). 2017;32(1):106\u201314.","journal-title":"Endocrinol Metab (Seoul)"},{"key":"5428_CR25","unstructured":"Park EJ, Bae JE, Song ES, Jeong Y, Choi S, Lee EJ, Kim EJ, Yeom AR, Yoon YM, Kim GS, Park HA, Lee YM, Yoon YJ. A report on the Korea health panel survey of 2018 (II): disease morbidity, chronic diseases, health behaviors, and health status.\u00a0\u00a0Wonju: Korea Institute for Health and Social Affairs; 2020. (in Korean)."},{"key":"5428_CR26","doi-asserted-by":"publisher","first-page":"153473541985413","DOI":"10.1177\/1534735419854134","volume":"18","author":"E Jones","year":"2019","unstructured":"Jones E, Nissen L, McCarthy A, Steadman K, Windsor C. Exploring the Use of Complementary and Alternative Medicine in Cancer Patients. Integr Cancer Ther. 2019;18:1534735419854134.","journal-title":"Integr Cancer Ther"},{"key":"5428_CR27","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1177\/1534735420983910","volume":"19","author":"CY Chin","year":"2020","unstructured":"Chin CY, Chen YH, Wu SC, Liu CT, Lee YF, Tsai MY. Complementary and alternative medicine use in breast cancer patients at a medical center in Taiwan: a cross-sectional study. Integr Cancer Ther. 2020;19:1552\u2013X695.","journal-title":"Integr Cancer Ther"},{"issue":"1","key":"5428_CR28","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1186\/s12906-020-03157-2","volume":"20","author":"M Tangkiatkumjai","year":"2020","unstructured":"Tangkiatkumjai M, Boardman H, Walker DM. Potential factors that influence usage of complementary and alternative medicine worldwide: a systematic review. BMC Complement Med Ther. 2020;20(1):363.","journal-title":"BMC Complement Med Ther"},{"key":"5428_CR29","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.5888\/pcd13.150501","volume":"13","author":"L Falci","year":"2016","unstructured":"Falci L, Shi ZX, Greenlee H. Multiple chronic conditions and use of complementary and alternative medicine among US adults: results from the 2012 national health interview survey. Prev Chronic Dis. 2016;13:1545\u2013151.","journal-title":"Prev Chronic Dis"},{"issue":"2","key":"5428_CR30","first-page":"442","volume":"55","author":"JS Kim","year":"2023","unstructured":"Kim JS, Kwon JH, Rha SY, Lee S-C, Chang YJ, Kwon I-S, You KH, Yoon HY. Status of using complementary and alternative medicine among patients with cancer in Korea: an online survey of online cancer support groups (KCSG PC21-20). Cancer Res Treat. 2023;55(2):442\u201351.","journal-title":"crt"},{"issue":"4","key":"5428_CR31","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1177\/1534735405282361","volume":"4","author":"MJ Verhoef","year":"2005","unstructured":"Verhoef MJ, Balneaves LG, Boon HS, Vroegindewey A. Reasons for and Characteristics Associated With Complementary and Alternative Medicine Use Among Adult Cancer Patients: A Systematic Review. Integr Cancer Ther. 2005;4(4):274\u201386.","journal-title":"Integr Cancer Ther"},{"key":"5428_CR32","doi-asserted-by":"publisher","unstructured":"Matos LC, Machado JP, Monteiro FJ, Greten HJ. Understanding traditional Chinese medicine therapeutics: an overview of the basics and clinical applications. Healthcare (Basel). 2021;9(3):257. https:\/\/doi.org\/10.3390\/healthcare9030257.","DOI":"10.3390\/healthcare9030257"},{"issue":"18","key":"5428_CR33","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.3390\/cancers16183130","volume":"16","author":"S Choi","year":"2024","unstructured":"Choi S, Karki Kunwor S, Im H, Choi D, Hwang J, Ahmed M, Han D. Traditional and complementary medicine use among cancer patients in Asian countries: A systematic review and meta-analysis. Cancers. 2024;16(18):3130.","journal-title":"Cancers"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-026-05428-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-026-05428-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-026-05428-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:18:23Z","timestamp":1788484703000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12906-026-05428-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5428"],"URL":"https:\/\/doi.org\/10.1186\/s12906-026-05428-w","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"31 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A portion of this study was presented in abstract form at the AOCE-SICEM 2023 (Asia Oceanian Congress of Endocrinology and Seoul International Congress of Endocrinology and Metabolism 2023) in Seoul, Korea.","order":1,"name":"Ethics","label":"Declarations","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The study protocol was reviewed and approved by the Institutional Review Board of each participating institution (trial registration number: KCT0004989). The written informed consent was received from all study participants.The ethics committees of the participating institutions approved the study protocol as follows: Seoul National University Hospital (H-1912-012-1084), Nowon Eulji Medical Center (EMCS 2020-04-020), Asan Medical Center (2020-0529), Inje University Busan Paik Hospital (19-0227), Chungnam National University Hospital (CNUH2020-03-091), Chungnam National University Sejong Hospital (CNUSH2020-11-018), Konyang University Hospital (KYUH2020-05-015), Daegu Catholic University Hospital (CR-20-125-L), Samsung Medical Center (SMC 2020-09-184), National Cancer Center (NCC 2020-0109), Seoul Metropolitan Government Seoul National University Boramae Medical Center (10-2020-035), Severance Hospital (2020-0202-001), Chungbuk National University Hospital (2019-11-012), Eulji University Hospital (2020-02-005), Dankook University Hospital (2019-11-033), Seoul National University Bundang Hospital (B-2006\/618-403), Ewha Womans University Seoul Medical Center (SEUMC 2019-11-035), Hallym University Sacred Heart Hospital (HALLYM 2019-05-022), Pusan National University Hospital (H-2006-023-091), Seoul St. Mary\u2019s Hospital (KC20EIDT0476), and the Gangnam Severance Hospital (2019-0794-001).","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"264"}}